Individuals with confirmed FMF are treated with colchicine.
Individuals with suggestive symptoms and negative genetic testing for MEFV may have FMF or another condition and are likely to benefit from specialist referral and additional testing, which may include MEFV sequencing or testing for related conditions including TRAPS and MKD.
FMF: familial Mediterranean fever; MKD: mevalonate kinase deficiency; TNF: tumor necrosis factor; TRAPS: TNF receptor associated periodic fever syndrome; VUS: variant of uncertain significance.
* Biallelic variants include homozygosity for a pathogenic variant or compound heterozygosity for two different pathogenic variants (one from each parent).